Navigation Links
Reliv’s LunaRich X Wins People’s Choice Stevie Award
Date:8/21/2013

Chesterfield, MO (PRWEB) August 21, 2013

Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich X™ was named winner of the People’s Choice Stevie® Award for Favorite New Consumer Product in the 11th Annual American Business Awards.

"We know we have created a breakthrough product in LunaRich X, and this award helps confirm that,” said Dr. Carl Hastings, Reliv vice chairman and chief scientific officer. "But our greatest reward comes from hearing the remarkable health results people are achieving with the help of this cutting-edge nutritional solution.”

LunaRich X won the People’s Choice Award by polling more online votes than innovative products made by the Delta Faucet Company, Zing Anything and other companies. This is the second People’s Choice Stevie Award for Reliv. Reliv’s healthy energy shot 24K™ earned the honor in 2011.

The American Business Awards are the nation’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations — public and private, for-profit and non-profit, large and small. More than 3,200 nominations were submitted to this year’s American Business Awards for consideration in a wide range of categories.

What Is LunaRich X?

LunaRich X is the most pure, concentrated form of lunasin ever produced. Lunasin is a naturally occurring peptide scientists have identified as responsible for many of soy’s documented health benefits, including cholesterol support and general cellular health. Learn more about the benefits of lunasin.

Just one 125mg capsule of LunaRich X delivers the same amount of bioactive lunasin found in 25 grams of high-quality soy protein, the daily amount identified by the Food and Drug Administration to help reduce the risk of heart disease.

Lunasin is one of the first bioactive compounds identified to affect gene expression and promote optimal health at the epigenetic level. The epigenome, which literally means “beyond the genome,” is a higher level of complexity within the cell. Learn more about lunasin and nutritional epigenetics.

LunaRich X marks the culmination of an extensive research and development process that began with the discovery of the lunasin peptide by research scientist Dr. Alfredo Galvez at UC Berkley in 1996. Lunasin is now one of the most heavily researched and scientifically supported nutritional compounds available today, with more than 50 published papers from more than 25 research institutions.

About Reliv International, Inc.
Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy’s health benefits. The company sells its products through an international network marketing system of independent distributors in 16 countries. Learn more about Reliv at http://www.reliv.com, or on Facebook, Twitter or YouTube.

About the Stevie Awards
Stevie Awards are conferred in four programs: The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. A fifth program, the Asia-Pacific Stevie Awards, will debut this year. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com/.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11045419.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Reliv’s LunaRich X Named Finalist for 2013 American Business Awards
2. Reliv’s LunaRich Earns Ingredient Patent
3. Dr. Kent Stobaugh Retiring from Oral & Maxillofacial Surgeons to Pursue Different Opportunities: SA4i Emphasizes Significant Contributions to People’s Lives
4. Voting Open for the ISE® West People’s Choice Awards
5. Healthy Lifestyle Choices Could Cut Cancer Rates: Report
6. ALS patients differ on treatment choices in later phases of disease
7. Obesity genes may influence food choices, eating patterns
8. Preteen Food Choices May Help Predict Eating Disorders Later
9. Teens Lifestyle Choices Affect Their Blood Pressure
10. Color-coded labels improve healthy food choices in employees from all backgrounds
11. Study helps pancreatic cancer patients make hard choices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents her ... 9--24, 2017. This sacred and spiritual journey during the Summer Solstice will ...
(Date:3/24/2017)... ... March 24, 2017 , ... On June ... ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will present on: ... of cases litigated under ERISA involve claims for long-term disability benefits. This ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower ... upgrading their training and leads programs. , In February, 2017, Empower Brokerage introduced ... agents, Performance Partners is designed to teach how to maximize their sales efforts, ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of Christian ... Bible teacher residing in North Carolina with his wife, Anna Marie. He and his ... six grandchildren. David is also the author of “Shadow and Substance.” , “Love, the ...
(Date:3/23/2017)... ... ... A recent report from the National Council on Teacher Quality (NCTQ) advocates ... based on a review of GPA and SAT/ACT requirements at 221 institutions in 25 ... argues that this higher bar should be set by states, by the Council for ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... GENEVA , March 24, 2017 ... revitalizes efforts to develop sutezolid as effective response to ... Day, TB Alliance and the Medicines Patent Pool (MPP) ... sutezolid, an antibiotic drug candidate which demonstrated encouraging results ... of sutezolid in combination with other TB drugs and ...
(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... Repair Procedure By Technique, By Region, By Country (2016-2021)" report ... ... a CAGR of 13.35% during 2016-2021 The strong growth ... in population with heart disease and rising advances in minimally invasive ...
(Date:3/23/2017)... March 23, 2017  The U.S. Food and Drug ... the treatment of adults and pediatric patients 12 years ... those who have not received prior chemotherapy. This is ... aggressive form of skin cancer. "While skin ... with a rare form called Merkel cell cancer have ...
Breaking Medicine Technology: